practical considerations for immunotherapy in stage 3 nsclc
Published 6 years ago • 338 plays • Length 9:57Download video MP4
Download video MP3
Similar videos
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
7:44
immunotherapy in stage iii nsclc
-
7:44
immunotherapy in stage iii nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
1:13
immunotherapy in stage iii nsclc metastatic disease
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
2:10
unmet needs and role of immunotherapy in stage 3 nsclc
-
1:02:36
practice changes for use of immunotherapy in nsclc
-
6:32
radiation therapy in stage 3 nsclc
-
2:20
dr. antonia on investigational immunotherapy combinations in stage iii nsclc
-
11:38
immunotherapy for management of stage 3b nsclc
-
1:39
frontline i-o strategies in sclc: practical implications
-
6:20
immunotherapy in stage iii nsclc: practice-changing results of pacific trial (bmic-006)
-
8:23
the pacific trial in stage 3 nsclc
-
5:00
implications for pembrolizumab in nsclc
-
5:31
practice changes for use of immunotherapy in nsclc: q&a
-
3:05
nsclc: consolidation immunotherapy in practice